Enterprise Value to EBITDA Ratio: CVS Health Corporation (CVS)

CVS Health Corporation (CVS) relies on the synergy between insurance and pharmacy retail, which minimizes dependence on external suppliers. The current EV/EBITDA valuation reflects the business value relative to earnings, while 8.83 captures the magnitude of this parameter. Revenue is generated through the sale of medications and health insurance, although rising patient costs are currently weighing on overall margins.

CVS CVS Corp: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 11/15/2026

Comprehensive metric breakdowns and analytics for CVS Health (CVS)

- current price and projected stock value:

Stock Price CVS Health Corporation|CVS - Consensus Target

- company stock exchange capitalization indicators:

Market Valuation CVS Health|CVS - Total Company Value

- business book valuation details:

Net Assets per Single Share CVS|CVS - Book Valuation of Business|Market Cap to Net Assets Ratio cvshealth.com|CVS - Aggregate Asset Value

- business debt structure and liquidity details:

- business earnings and investment ratios data:

CVS - Profit After Payment of Taxes|Projected Future Earnings CVS Health Corporation|CVS - Company Value to Net Income|Projected Price to Earnings CVS Health Corporation|CVS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple CVS Health Corporation|CVS - Operating profit before deduction of amortization|Earnings per share for the last twelve months CVS|CVS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months cvshealth.com|CVS - Earnings per share increase in current year|Net earnings per share growth forecast for next year CVS Health Corporation

- sales volume and revenue indicators:

CVS - Company Annual Revenue|Company Projected Revenue CVS Health|CVS - Price to Sales|Price-to-Projected Revenue Ratio CVS Health Corporation|CVS - Revenue Dynamics YoY (Last Twelve Months)

Initial company analysis:CVS Health Corporation CVS

CVS Health Corporation (CVS) integrates pharmacy retail and insurance into a single consumption cycle, creating a capital-intensive infrastructure. The company's EV/EBITDA ratio compares the total enterprise value with operating profit, neutralizing the impact of tax regimes and asset depreciation. This allows investors to assess the real value of cash generation regardless of the debt load. Analyzing this chart helps identify overvalued quotes relative to the fundamental scale of the ecosystem in a timely manner.

Competitors of CVS Health Corporation

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization mckesson.com MCK|COR - Enterprise Value to EBITDA Ratio|cardinalhealth.com - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation HSIC (Henry Schein)|PBH: EV/EBITDA Multiple|Company Value to EBITDA Wellgistics (WGRX)|Enterprise Value to Operating Income Before Depreciation 111 Inc (YI)|jiuzhou360.com (RDGT) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple UPC|Biodexa Pharmaceuticals PLC - Enterprise Value to Operating Income Before Depreciation|Hong Kong Pharma Digital - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation BIMI|CJJD: Enterprise Value to EBITDA Ratio|Company Value to EBITDA Walgreens Boots Alliance, Inc.